Panulde, Rachel .

HRN: 27-92-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
AMPICILLIN 1GM (VIAL)
10/15/2025
10/21/2025
IV
2 Grams
Q6H
Premature Rupture Of Membranes
Waiting Final Action 
10/16/2025
CEFUROXIME 1.5GM (VIAL)
10/16/2025
10/17/2025
IVTT
1.5g
Q8h
SP LTCS
Waiting Final Action 
10/16/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/16/2025
10/17/2025
IVTT
500mg
Q8h
SP LTCS
Waiting Final Action 
10/17/2025
CEFUROXIME 500MG (TAB)
10/17/2025
10/23/2025
PO
500mg Tab
1 Tab BID X 7 Days
S/p Cs
Waiting Final Action 
10/17/2025
METRONIDAZOLE 500MG (TAB)
10/17/2025
10/23/2025
PO
500mg
1 Tab TID X 7 Days
S/p Cs
Waiting Final Action 
10/19/2025
CEFUROXIME 500MG (TAB)
10/19/2025
10/24/2025
PO
500mg
BID
SP LTCS
Waiting Final Action 
10/19/2025
METRONIDAZOLE 500MG (TAB)
10/19/2025
10/24/2025
PO
500mg
TID
SP LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: